Quantifying emissions and enhancing inclusivity: Insights from ASCO attendance data.

Authors

null

Katie Lichter

University of California, San Francisco, San Francisco, CA

Katie Lichter, Ali Sabbagh, Sasha Demeulenaere, Taylor Drew, Alexandra Conway, Leticia M Nogueira, Margaret Kelsey Kirkwood, Jasmine Kamboj, Karly Hampshire, Katherine Gundling, Arianne Teherani, Sapna Thottathil, Osama Mohamad

Organizations

University of California, San Francisco, San Francisco, CA, Loyola University Chicago Stritch School of Medicine, Chicago, IL, Loyola University Chicago School of Medicine, Chicago, IL, Dartmouth Geisel School of Medicine, White River Junction, NH, American Cancer Society, Atlanta, GA, ASCO, Alexandria, VA, Allina Health Cancer Institute – Piper Breast Center – Minneapolis, River Falls, WI, Columbia University Medical Center, New York, NY, University of California, San Francisco, Palo Alto, CA, University of California Center for Climate, Health and Equity, Oakland, CA

Research Funding

Other
San Francisco Bay Physicians for Social Responsibility Trainee grant

Background: In-person conference attendance contributes significantly to a professional’s annual greenhouse gas (GHG) emissions. However, estimating conference emissions has often relied on assumptions about attendee numbers and travel, especially for investigations of medical conferences. This project aims to address these limitations by utilizing actual attendance data from the American Society of Clinical Oncology’s (ASCO) Annual Meetings. The objectives of this project are to establish a quantitative baseline of conference-associated emissions for different formats (in-person, virtual, and hybrid) and simulate changes to conference parameters with evaluation of associated emissions to provide recommendations for sustainable changes. Methods: Data was provided by ASCO including the number of attendees, zip codes of origin, and attendance method (in-person versus virtual) for their 2019-2022 Annual Meetings. Using a variety of conservative assumptions, emissions were calculated with consideration of the following factors: travel versus virtual attendance, conference space utilization, hotel stays, and electricity. The results were stratified by country, attendance method, and year, and differences in emissions were assessed with t-tests. Simulations were conducted to evaluate the impact of different conference sizes, locations, and formats on emissions. Results: The highest estimated GHG emissions were associated with the in-person 2019 conference, totaling 37,251 metric tons of carbon dioxide equivalents. While international attendees accounted for the largest proportion of emissions (>50%) in all years, optimizing conference locations models only reduced emissions by 3%. However, simulations of hub-and-spoke models showed the potential for larger decreases of up to 86%, and various hybrid models offered similar emission savings. Furthermore, hybrid conferences in 2020 and 2021 demonstrated increased attendee diversity with a higher percentage of international attendees compared to the in-person 2019 conference (44% international attendance in 2019 versus 53% in 2020 and 54% in 2021). Conclusions: This study not only quantifies the emissions impact of alternative conference formats but also highlights the importance of diversity, equity, and inclusion (DEI) considerations in reducing emissions. While travel remains a significant contributor to conference emissions, conference models focusing solely on location optimization were not as effective as hybrid models in reducing emissions. Hybrid models may present an opportunity to effectively mitigate GHG emissions while maintaining networking opportunities and cultivating inclusivity for attendees from diverse backgrounds.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Quality Improvement Research and Implementation Science

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 442)

DOI

10.1200/OP.2023.19.11_suppl.442

Abstract #

442

Poster Bd #

J24

Abstract Disclosures